Here’s everything we know about it so far
China is experiencing a surge in Human Metapneumovirus (HMPV) infections after five years of the Covid-19 pandemic. Reports and online posts indicate widespread transmission, with some claiming hospitals and crematories are overwhelmed. Videos circulating online depict crowded hospitals, and users mention the simultaneous circulation of influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19. Some reports link the rise in HMPV to an increase in deaths, particularly among people aged 40 to 80.
“China is facing a surge in multiple viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19, overwhelming hospitals and crematoriums. Children’s hospitals are particularly strained by rising pneumonia and ‘white lung’ cases,” a social media post stated.
What is HMPV Virus?
Discovered in 2001, HMPV is part of the Pneumoviridae family, which also includes RSV. Studies suggest it has been present in humans for over 60 years globally. The virus causes respiratory illness in people of all ages, particularly affecting young children, older adults, and those with weakened immune systems.
Symptoms include cough, fever, nasal congestion, and shortness of breath. Transmission occurs through respiratory droplets and contact with contaminated objects. The incubation period is three to five days. Preventive measures include wearing masks, frequent handwashing, and boosting immunity. Experts advise against using antivirals for HMPV. A Shanghai respiratory expert warned against using antiviral drugs for HMPV, stating it has no vaccine and symptoms similar to a cold. In 2023, HMPV was detected in several countries, including the Netherlands, Britain, Finland, Australia, Canada, the US, and China.
